Cargando…

The Diskus™: a review of its position among dry powder inhaler devices

The use of dry powder inhalers (DPIs) to administer treatments for respiratory diseases has increased significantly in recent years. There is now a wide range of DPIs available that vary considerably in design, required operational techniques, output characteristics and drug delivery across a range...

Descripción completa

Detalles Bibliográficos
Autor principal: Chrystyn, H
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1974824/
https://www.ncbi.nlm.nih.gov/pubmed/17504364
http://dx.doi.org/10.1111/j.1742-1241.2007.01382.x
_version_ 1782135048796897280
author Chrystyn, H
author_facet Chrystyn, H
author_sort Chrystyn, H
collection PubMed
description The use of dry powder inhalers (DPIs) to administer treatments for respiratory diseases has increased significantly in recent years. There is now a wide range of DPIs available that vary considerably in design, required operational techniques, output characteristics and drug delivery across a range of inhalation patterns. Different patient populations may find individual types of DPI easier to use correctly than others and selecting the right DPI for particular patient requirements will improve compliance with therapy. For example, some DPIs offer a greater resistance against inspirational flow rate than others which affects the total emitted dose and also fine particle mass of the aerosol released. An individual patient may therefore receive different amounts of drug when inhaling from different DPIs. Therefore, it is important that the prescriber is fully aware of the characteristics of the different types of DPI, so that he or she can prescribe the device that is most appropriate to an individual patient's needs. This review explores the characteristics of currently available DPIs and evaluates their efficacy and patient acceptability. The differences in output characteristics, ease of use and patient preferences between available devices is shown to affect treatment efficacy and patient compliance with therapy. Changing the DPI prescribed to a patient to a cheaper or generic device may therefore adversely affect disease control and thereby increase the cost of treatment.
format Text
id pubmed-1974824
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-19748242007-09-18 The Diskus™: a review of its position among dry powder inhaler devices Chrystyn, H Int J Clin Pract Review Articles The use of dry powder inhalers (DPIs) to administer treatments for respiratory diseases has increased significantly in recent years. There is now a wide range of DPIs available that vary considerably in design, required operational techniques, output characteristics and drug delivery across a range of inhalation patterns. Different patient populations may find individual types of DPI easier to use correctly than others and selecting the right DPI for particular patient requirements will improve compliance with therapy. For example, some DPIs offer a greater resistance against inspirational flow rate than others which affects the total emitted dose and also fine particle mass of the aerosol released. An individual patient may therefore receive different amounts of drug when inhaling from different DPIs. Therefore, it is important that the prescriber is fully aware of the characteristics of the different types of DPI, so that he or she can prescribe the device that is most appropriate to an individual patient's needs. This review explores the characteristics of currently available DPIs and evaluates their efficacy and patient acceptability. The differences in output characteristics, ease of use and patient preferences between available devices is shown to affect treatment efficacy and patient compliance with therapy. Changing the DPI prescribed to a patient to a cheaper or generic device may therefore adversely affect disease control and thereby increase the cost of treatment. Blackwell Publishing Ltd 2007-06 /pmc/articles/PMC1974824/ /pubmed/17504364 http://dx.doi.org/10.1111/j.1742-1241.2007.01382.x Text en © 2007 The Authors Journal compilation 2007 Blackwell Publishing Ltd
spellingShingle Review Articles
Chrystyn, H
The Diskus™: a review of its position among dry powder inhaler devices
title The Diskus™: a review of its position among dry powder inhaler devices
title_full The Diskus™: a review of its position among dry powder inhaler devices
title_fullStr The Diskus™: a review of its position among dry powder inhaler devices
title_full_unstemmed The Diskus™: a review of its position among dry powder inhaler devices
title_short The Diskus™: a review of its position among dry powder inhaler devices
title_sort diskus™: a review of its position among dry powder inhaler devices
topic Review Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1974824/
https://www.ncbi.nlm.nih.gov/pubmed/17504364
http://dx.doi.org/10.1111/j.1742-1241.2007.01382.x
work_keys_str_mv AT chrystynh thediskusareviewofitspositionamongdrypowderinhalerdevices
AT chrystynh diskusareviewofitspositionamongdrypowderinhalerdevices